Is Palatin Technologies, Inc. Common Stock (PTN) overvalued? · P/E 111, $21.8M cap
Palatin Technologies, Inc. Common Stock (PTN) is a biotechnology company listed on NASDAQ.
This page asks whether Palatin Technologies, Inc. Common Stock (PTN) looks expensive on cached numbers — not a short thesis.
Latest reported PTN revenue for 2025-06-30 was $0. Net income was -$17.3M. Revenue was down 100.0% from 2024-06-30 to 2025-06-30. PTN currently screens at market cap $21.8M and trailing P/E 111.4.
PTN currently screens at market cap $21.8M and trailing P/E 111.4. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next PTN 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the PTN stock page for the full model, not this heading.
Not investment advice.